AU5182099A - Pharmaceutical formulation - Google Patents
Pharmaceutical formulationInfo
- Publication number
- AU5182099A AU5182099A AU51820/99A AU5182099A AU5182099A AU 5182099 A AU5182099 A AU 5182099A AU 51820/99 A AU51820/99 A AU 51820/99A AU 5182099 A AU5182099 A AU 5182099A AU 5182099 A AU5182099 A AU 5182099A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9817470.9A GB9817470D0 (en) | 1998-08-11 | 1998-08-11 | Pharmaceutical formulation |
GB9817470 | 1998-08-11 | ||
PCT/GB1999/002527 WO2000009084A2 (en) | 1998-08-11 | 1999-08-02 | Biodegradable microparticles gel composition |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5182099A true AU5182099A (en) | 2000-03-06 |
Family
ID=10837065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU51820/99A Abandoned AU5182099A (en) | 1998-08-11 | 1999-08-02 | Pharmaceutical formulation |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1105095A2 (en) |
JP (1) | JP2002522467A (en) |
AU (1) | AU5182099A (en) |
CA (1) | CA2340177A1 (en) |
GB (1) | GB9817470D0 (en) |
WO (1) | WO2000009084A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6632457B1 (en) * | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
EP1446104B2 (en) | 2001-11-01 | 2011-08-03 | Novartis AG | Spray drying methods |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
BR102012011209A2 (en) * | 2012-05-11 | 2014-03-25 | Bioactive Biomateriais Ltda | BIODEGRADABLE THREE-DIMENSIONAL MATERIAL AND BIODEGRADABLE THREE-DIMENSIONAL MATERIAL PREPARATION PROCESS |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9107628D0 (en) * | 1991-04-10 | 1991-05-29 | Moonbrook Limited | Preparation of diagnostic agents |
IT1255076B (en) * | 1992-04-01 | 1995-10-18 | Inverni Della Beffa Spa | BIODEGRADABLE MICROSPHERES FOR PHARMACEUTICAL AND COSMETIC USE |
WO1993025221A1 (en) * | 1992-06-11 | 1993-12-23 | Alkermes Controlled Therapeutics, Inc. | Erythropoietin drug delivery system |
-
1998
- 1998-08-11 GB GBGB9817470.9A patent/GB9817470D0/en not_active Ceased
-
1999
- 1999-08-02 WO PCT/GB1999/002527 patent/WO2000009084A2/en not_active Application Discontinuation
- 1999-08-02 CA CA002340177A patent/CA2340177A1/en not_active Abandoned
- 1999-08-02 JP JP2000564587A patent/JP2002522467A/en active Pending
- 1999-08-02 AU AU51820/99A patent/AU5182099A/en not_active Abandoned
- 1999-08-02 EP EP99936846A patent/EP1105095A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB9817470D0 (en) | 1998-10-07 |
EP1105095A2 (en) | 2001-06-13 |
JP2002522467A (en) | 2002-07-23 |
CA2340177A1 (en) | 2000-02-24 |
WO2000009084A3 (en) | 2000-06-02 |
WO2000009084A2 (en) | 2000-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
HK1041224A1 (en) | New pharmaceutical formulation | |
AU6740298A (en) | Pharmaceutical composition | |
AU4413299A (en) | Stabilized pharmaceutical compositions | |
AU4328800A (en) | Pharmaceutical formulation | |
AU8107998A (en) | Pharmaceutical compositions | |
AU1409100A (en) | Drugs | |
AU6715600A (en) | Pharmaceutical formulations | |
AU9343098A (en) | Pharmaceutical composition | |
AU4977300A (en) | Pharmaceutical formulations | |
AU1385801A (en) | Pharmaceutical formulations | |
GB9818927D0 (en) | Pharmaceutical formulation | |
AUPP332898A0 (en) | Pharmaceutical composition | |
AU6480299A (en) | Pharmaceutical compounds | |
AU1688099A (en) | Pharmaceutical preparation | |
AU5378599A (en) | Oral formulation | |
AU3839900A (en) | Pharmaceutical formulation | |
AU5182099A (en) | Pharmaceutical formulation | |
GB9822333D0 (en) | Pharmaceutical formulation | |
AU1388501A (en) | Pharmaceutical formulation | |
AU5184599A (en) | Pharmaceutical compounds | |
AU2279800A (en) | Pharmaceutical preparation | |
AU1649700A (en) | Novel formulation | |
AU3989100A (en) | Pharmaceutical gel formulation | |
ZA994697B (en) | Pharmaceutical formulation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |